About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNNCT01122225

Neutrophile Gelatinase Associated Lipocalin Evaluation in Septic Acute Kidney Injury

Acute kidney injury (AKI) is a major organ failure in septic shock. Current medical tests (serum creatinine and urea) cannot identify AKI until approximately 48 hours after it occurs. Neutrophil gelat...

Lead sponsor: Université Victor Segalen Bordeaux 2•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Université Victor Segalen Bordeaux 2

Collaborators

Inverness Medical Innovations

Primary Outcome Measures: To correlate elevated serum NGAL with the diagnosis of intrinsic acute kidney injury in septic shock Secondary Outcome Measures : To compare serum NGAL with serum creatinine, serum urea and urine output in septic AKI Death within the intensive care unit Death from all causes at 28 days after inclusion

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients showing signs of infection and hypotension requiring the use of epinephrine despite of an appropriate fluid challenge.
•18 years of age or older

Exclusion Criteria

•Age under 18 years
•Prisoners or other institutionalized or vulnerable individuals
•Participation in an interventional clinical study within the previous 30 days

Related studies

Kidney Precision Medicine Project

NCT04334707 · Acute Kidney Failure, Acute Kidney Insufficiency, and more

Active Not Recruiting

Immune Function in Acute Kidney Injury

NCT02470507 · Acute Kidney Failure

Not Yet Recruiting

Assessment of AI Prediction Models in Prediction of Acute Kidney Injury in Critical Patients

NCT06857188 · Acute Kidney Failure, Artificial Intelligence (AI)

WITHDRAWNPhase 4

High Versus Low Bicarbonate Bath in Critically-ill Patients Receiving Continuous Renal Replacement Therapy

NCT03846258 · Metabolic Acidosis, Acute Kidney Injury, and more

Q10 Preloading Before Cardiac Surgery for Kidney Failure Reduction

NCT04445779 · Acute Kidney Injury, Acute Kidney Failure

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 31, 2010Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment50

Start dateJul 2009

Last updatedMay 31, 2010

Condition

Acute Kidney Failure

Locations shown

Reanimation medicale, Hopital Saint-Andre, Bordeaux University Hospital

Bordeaux, Aquitaine

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 31, 2010Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions